These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27062497)

  • 1. Valuation of pemphigus vulgaris and pemphigus foliaceus health states: a convenience sample experiment.
    Rencz F; Brodszky V; Stalmeier PF; Tamási B; Kárpáti S; Péntek M; Baji P; Mitev AZ; Gulácsi L
    Br J Dermatol; 2016 Sep; 175(3):593-9. PubMed ID: 27062497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus.
    Hajdu K; Brodszky V; Stalmeier PFM; Ruzsa G; Tamási B; Gulácsi L; Péntek M; Sárdy M; Bata-Csörgő Z; Kinyó Á; Szegedi A; Rencz F
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2106-2113. PubMed ID: 31265151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
    Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
    Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lead time tradeoff: the case of health states better than dead.
    Pinto-Prades JL; Rodríguez-Míguez E
    Med Decis Making; 2015 Apr; 35(3):305-15. PubMed ID: 25009190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Health utility measurement by time trade-off method in Hungary].
    Balázs PG; Brodszky V; Rencz F
    Orv Hetil; 2021 Mar; 162(14):542-554. PubMed ID: 33784247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elicitation of health state utilities associated with differing durations of morning stiffness in rheumatoid arthritis.
    Iqbal I; Dasgupta B; Taylor P; Heron L; Pilling C
    J Med Econ; 2012; 15(6):1192-200. PubMed ID: 22804691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health state utilities for metastatic breast cancer in Taiwan.
    Chou TC; Chiang SC; Ko Y
    Breast; 2020 Jun; 51():57-64. PubMed ID: 32213442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gap effect: discontinuities of preferences around dead.
    Stalmeier PF; Busschbach JJ; Lamers LM; Krabbe PF
    Health Econ; 2005 Jul; 14(7):679-85. PubMed ID: 15744750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescue.
    Iskedjian M; Tinmouth AT; Arnold DM; Deuson R; Isitt JJ; Mikhael J
    J Med Econ; 2012; 15(2):313-31. PubMed ID: 22136485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valuing Treatments for Parkinson Disease Incorporating Process Utility: Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales.
    Weernink MG; Groothuis-Oudshoorn CG; IJzerman MJ; van Til JA
    Value Health; 2016; 19(2):226-32. PubMed ID: 27021757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of methods for converting DCE values onto the full health-dead QALY scale.
    Rowen D; Brazier J; Van Hout B
    Med Decis Making; 2015 Apr; 35(3):328-40. PubMed ID: 25398621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.
    Essink-Bot ML; Stuifbergen MC; Meerding WJ; Looman CW; Bonsel GJ;
    BMC Health Serv Res; 2007 Apr; 7():62. PubMed ID: 17466068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valuing health status using VAS and TTO: what lies behind the numbers?
    Robinson A; Dolan P; Williams A
    Soc Sci Med; 1997 Oct; 45(8):1289-97. PubMed ID: 9381241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thigh laxity after massive weight loss: a utilities outcomes assessment.
    Izadpanah A; Sinno H; Vorstenbosch J; Lee BT; Lin SJ
    Ann Plast Surg; 2013 Sep; 71(3):304-7. PubMed ID: 23788144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study.
    Schmitt J; Meurer M; Klon M; Frick KD
    Br J Dermatol; 2008 Feb; 158(2):351-9. PubMed ID: 18070214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO.
    Heintz E; Wiréhn AB; Peebo BB; Rosenqvist U; Levin LÅ
    Value Health; 2012 May; 15(3):475-84. PubMed ID: 22583458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.